{
  "title": "This Drug Maker Saw the Pandemic Coming",
  "itunes:title": "This Drug Maker Saw the Pandemic Coming",
  "description": "<p>When Covid-19 hit, Gilead Sciences Inc. had enough of its experimental drug remdesivir ready to test and start manufacturing it at a larger scale. That's because it had started stockpiling not just the drug, but its ingredients, at the first hint there may be a new coronavirus. Robert Langreth reports on why the company was able to act early to prepare for a pandemic when so many businesses and institutions did not.</p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "content:encoded": "<p>When Covid-19 hit, Gilead Sciences Inc. had enough of its experimental drug remdesivir ready to test and start manufacturing it at a larger scale. That's because it had started stockpiling not just the drug, but its ingredients, at the first hint there may be a new coronavirus. Robert Langreth reports on why the company was able to act early to prepare for a pandemic when so many businesses and institutions did not.</p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "itunes:episodeType": "full",
  "itunes:season": 5,
  "itunes:episode": 35,
  "itunes:author": "Bloomberg",
  "itunes:image": "",
  "media:content": [
    {
      "media:player": ""
    },
    ""
  ],
  "guid": "95fc30d2-9624-11ea-8ea8-7f898dfd5743",
  "omny:clipId": "87200cb6-3363-455d-b24b-ae3900971d73",
  "pubDate": "Thu, 14 May 2020 20:49:00 +0000",
  "itunes:duration": 811,
  "enclosure": "",
  "link": "https://omny.fm/shows/prognosis-breakthrough/this-drug-maker-saw-the-pandemic-coming"
}